Bristol-Myers Squibb Company
US ˙ NYSE ˙ US1101221083

SecurityBMY / Bristol-Myers Squibb Company
InstitutionFirst Command Bank
Latest Disclosed Ownership18,003 shares
Latest Disclosed Value $ 1,151,292
First Command Bank reports 2.94% decrease in ownership of BMY / Bristol-Myers Squibb Company

On July 21, 2023 - First Command Bank filed a 13F-HR form disclosing ownership of 18,003 shares of Bristol-Myers Squibb Company (US:BMY) valued at $1,151,292 USD as of June 30, 2023. The entity filed a previous 13F-HR on April 14, 2023 disclosing 18,548 shares of Bristol-Myers Squibb Company. This represents a change in shares of -2.94% during the quarter. The current value of the position is $1,031,032 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2023-07-21 2023-06-30 13F Bristol Myers Squibb COM 110122108 18,003 -545 -2.94 1,151 -10.43 0.1083
2023-04-14 2023-03-31 13F Bristol Myers Squibb COM 110122108 18,548 -137 -0.73 1,286 128,400.00 0.1315
2023-01-23 2022-12-31 13F Bristol Myers Squibb COM 110122108 18,685 0 0.00 1 -99.92 0.1705
2022-10-24 2022-09-30 13F Bristol Myers Squibb COM 110122108 18,685 0 0.00 1,328 -7.71 0.1931
2022-08-24 2022-06-30 13F/A-1 Bristol Myers Squibb COM 110122108 18,685 -4,638 -19.89 1,439 -15.50 0.2097
2022-07-21 2022-06-30 13F Bristol Myers Squibb COM 110122108 18,685 -4,638 1,438 0.1226
2022-08-24 2022-03-31 13F/A-1 Bristol Myers Squibb COM 110122108 23,323 -1,292 -5.25 1,703 16.96 0.2335
2022-04-14 2022-03-31 13F Bristol Myers Squibb COM 110122108 45,629 21,014 3,332 0.3851
2022-01-25 2021-12-31 13F Bristol Myers Squibb COM 110122108 24,615 0 0.00 1,456 0.00 0.2498
2021-12-16 2021-09-30 13F Bristol Myers Squibb COM 110122108 24,615 0 0.00 1,456 -11.49 0.2498
2021-07-20 2021-06-30 13F Bristol Myers Squibb COM 110122108 24,615 10,069 69.22 1,645 79.19 0.1846
2021-04-20 2021-03-31 13F Bristol Myers Squibb COM 110122108 14,546 11,992 469.54 918 481.01 0.1981
2021-01-19 2020-12-31 13F Bristol Myers Squibb COM 110122108 2,554 -14 -0.55 158 1.94 0.0386
2020-10-20 2020-09-30 13F Bristol Myers Squibb COM 110122108 2,568 14 0.55 155 3.33 0.0441
2020-07-20 2020-06-30 13F/A-1 Bristol Myers Squibb COM 110122108 2,554 -100 -3.77 150 1.35 0.0479
2020-07-17 2020-06-30 13F Bristol Myers Squibb COM 110122108 2,554 -100 150 25,738.3474
2020-04-20 2020-03-31 13F Bristol Myers Squibb COM 110122108 2,654 -345 -11.50 148 -22.92 0.0802
2020-01-14 2019-12-31 13F Bristol Myers Squibb COM 110122108 2,999 997 49.80 192 88.24 0.0908
2019-10-15 2019-09-30 13F Bristol Myers Squibb COM 110122108 2,002 0 0.00 102 12.09 0.0515
2019-07-11 2019-06-30 13F Bristol Myers Squibb COM 110122108 2,002 -100 -4.76 91 -9.90 0.0459
2019-04-17 2019-03-31 13F Bristol Myers Squibb COM 110122108 2,102 0 0.00 101 -7.34 0.0502
2019-01-18 2018-12-31 13F Bristol Myers Squibb COM 110122108 2,102 0 0.00 109 -16.15 0.0563
2018-10-22 2018-09-30 13F Bristol Myers Squibb COM 110122108 2,102 0 0.00 130 12.07 0.0364
2018-07-20 2018-06-30 13F Bristol Myers Squibb COM 110122108 2,102 -500 -19.22 116 -29.27 0.0339
2018-04-12 2018-03-31 13F Bristol Myers Squibb COM 110122108 2,602 -400 -13.32 165 -10.87 0.0890
2018-01-12 2017-12-31 13F Bristol Myers Squibb COM 110122108 3,002 0 0.00 184 -4.17 0.1028
2017-10-10 2017-09-30 13F Bristol Myers Squibb COM 110122108 3,002 -300 -9.09 192 4.35 0.1196
2017-07-10 2017-06-30 13F/A-1 Bristol Myers Squibb COM 110122108 3,302 100 3.12 184 5.75 0.1208
2017-07-10 2017-06-30 13F Bristol Myers Squibb COM 110122108 3,302 184
2017-04-13 2017-03-31 13F Bristol Myers Squibb COM 110122108 3,202 -180 -5.32 174 -11.68 0.1223
2017-01-27 2016-12-31 13F Bristol Myers Squibb COM 110122108 3,382 3,382 197 0.1579
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.